TGF-β Receptors and Colorectal Cancer
Author Information
Author(s): Matsushita M, Matsuzaki K, Date M, Watanabe T, Shibano K, Nakagawa T, Yanagitani S, Amoh Y, Takemoto H, Ogata N, Yamamoto C, Kubota Y, Seki T, Inokuchi H, Nishizawa M, Takada H, Sawamura T, Okamura A
Primary Institution: Kansai Medical University
Hypothesis
The study aims to examine the expression of TGF-β and its receptors in human colorectal cancer tissue and determine any relationship with cancer growth.
Conclusion
The study found that colorectal cancer cells often down-regulate TGF-β receptors, which may contribute to cancer progression.
Supporting Evidence
- TGF-β receptor mRNAs were mainly expressed by normal colorectal epithelial cells and adenomas.
- TGF-β receptor mRNAs were faintly expressed in most colorectal cancers.
- Intense signals of TGF-β1 mRNA and protein were detected in all colorectal cancers.
- TGF-β receptor mRNAs and TGF-β1 protein were found in fibroblasts and endothelial cells.
- Smad 4 protein was translocated to the nucleus in adenoma cells but not in cancer cells after TGF-β stimulation.
Takeaway
Some cancer cells don't listen to a growth-stopping signal, which might help them grow more.
Methodology
The study used in situ hybridization, Northern blot hybridization, and immunohistochemical staining on human colorectal tissue samples.
Participant Demographics
The study included 11 human colorectal adenomas, 22 colorectal cancers, and 10 normal colorectal mucosas.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website